The effectiveness of the Interaktor app was evaluated in a randomized trial of patients undergoing radiotherapy for prostate cancer monitor and manage their symptoms.

Scientists have found a key weakness in prostate cancer cells. Two enzymes, PDIA1 and PDIA5, help cancer cells survive and ...

As a man over the age of 50 who has been treated for cancer, I may not be the most impartial witness when it comes to the ...

Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists in Australia.

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Researchers from Australia and China have found two enzymes that help cancer resist treatment. The experiments show that by ...

Preclinical study showed PDIA1 and PDIA5 protect cells from oxidative stress, maintain mitochondrial function, and are ...

A spokesperson for Joe Biden says the former Democratic president has completed several weeks of radiation therapy to treat ...

Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists. A new ...

SpaceOAR Hydrogel is a polyethylene glycol–based hydrogel designed to create space between the prostate and rectum to reduce ...

Combining 177 Lu-PSMA-617 with SOC produced statistically significant rPFS, reducing the risk of radiographic progression or death by 28% (HR 0.72; 95% CI, 0.58-0.90) vs SOC alone in patients with ...

In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis ...